Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Brucea javanica oil is an extract derived from the seeds of the Brucea javanica plant (Fructus Bruceae), a traditional Chinese medicinal herb. The primary active constituents are quassinoids (notably brusatol and bruceine D), triterpenes, alkaloids, and flavonoids. It has been widely used in Asia as an adjuvant therapy for various cancers—especially gastrointestinal and lung cancers—and for its anti-inflammatory and anti-malarial properties. Mechanistically, its anticancer effects are attributed to inhibition of tumor cell proliferation, induction of apoptosis via mitochondrial pathways, suppression of angiogenesis (formation of new blood vessels in tumors), modulation of immune responses (anti-inflammatory action), and interference with multiple signaling pathways such as PI3K/Akt/mTOR and JAK/STAT. It is also traditionally used for intestinal inflammation, diarrhea, malaria, and other conditions[2][4][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on brucea javanica oil.